v3.22.2.2
ACQUISITION–RELATED CHARGES (GAINS) AND OTHER (Tables)
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Acquisition Related Charges (Gains) And Other
Acquisition-related charges (gains) and other for the three and nine months ended September 30, 2022 and 2021 summarized below (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Severance-related expenses$194 $445 $4,259 $445 
Acquisition-related fees905 951 4,918 958 
Other acquisition expenses433 — 985 — 
Total acquisition-related charges1,532 1,396 10,162 1,403 
Flexion contingent consideration(520)— (13,837)— 
MyoScience contingent consideration(523)(1,159)(9,557)(2,147)
Nuance Biotech Co. Ltd. agreement dissolution costs— — — 3,000 
Total acquisition-related charges (gains) and other$489 $237 $(13,232)$2,256